Zika Virus: Immunity and Vaccine Development

被引：91
|
作者：
Pierson, Theodore C. [1 ]
Graham, Barney S. [2 ]
机构：
[1] NIAID, Viral Pathogenesis Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] NIAID, Viral Pathogenesis Lab, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
来源：
CELL | 2016年 / 167卷 / 03期
关键词：
WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; CD8(+) T-CELLS; DENGUE VIRUS; ENVELOPE PROTEIN; STRUCTURAL BASIS; NEUTRALIZING ANTIBODY; CROSS-REACTIVITY; SURFACE-PROTEINS;
D O I：
10.1016/j.cell.2016.09.020
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The emergence of Zika virus in the Americas and Caribbean created an urgent need for vaccines to reduce transmission and prevent disease, particularly the devastating neurodevelopmental defects that occur in utero. Rapid advances in Zika immunity and the development of vaccine candidates provide cautious optimism that preventive measures are possible.
引用
收藏
页码：625 / 631
页数：7
相关论文
共 50 条
  • [31] Zika Virus: Diagnosis, Therapeutics, and Vaccine
    Shan, Chao
    Xie, Xuping
    Barrett, Alan D. T.
    Garcia-Blanco, Mariano A.
    Tesh, Robert B.
    da Costa Vasconcelos, Pedro Fernando
    Vasilakis, Nikos
    Weaver, Scott C.
    Shi, Pei-Yong
    ACS INFECTIOUS DISEASES, 2016, 2 (03): : 170 - 172
  • [32] A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models
    Shan, Chao
    Muruato, Antonio E.
    Nunes, Bruno T. D.
    Luo, Huanle
    Xie, Xuping
    Medeiros, Daniele B. A.
    Wakamiya, Maki
    Tesh, Robert B.
    Barrett, Alan D.
    Wang, Tian
    Weaver, Scott C.
    Vasconcelos, Pedro F. C.
    Rossi, Shannan L.
    Shi, Pei-Yong
    NATURE MEDICINE, 2017, 23 (06) : 763 - +
  • [33] A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models
    Shan, Chao
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [34] A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models
    Chao Shan
    Antonio E Muruato
    Bruno T D Nunes
    Huanle Luo
    Xuping Xie
    Daniele B A Medeiros
    Maki Wakamiya
    Robert B Tesh
    Alan D Barrett
    Tian Wang
    Scott C Weaver
    Pedro F C Vasconcelos
    Shannan L Rossi
    Pei-Yong Shi
    Nature Medicine, 2017, 23 : 763 - 767
  • [35] Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans
    Malafa, Stefan
    Medits, Iris
    Aberle, Judith H.
    Aberle, Stephan W.
    Haslwanter, Denise
    Tsouchnikas, Georgios
    Woelfel, Silke
    Huber, Kristina L.
    Percivalle, Elena
    Cherpillod, Pascal
    Thaler, Melissa
    Rossbacher, Lena
    Kundi, Michael
    Heinz, Franz X.
    Stiasny, Karin
    PLOS NEGLECTED TROPICAL DISEASES, 2020, 14 (02):
  • [36] Role of Zika Virus prM Protein in Viral Pathogenicity and Use in Vaccine Development
    Nambala, Peter
    Su, Wen-Chi
    FRONTIERS IN MICROBIOLOGY, 2018, 9
  • [37] PRECLINICAL DEVELOPMENT OF A COMBINATION ZIKA AND CHIKUNGUNYA VIRUS-LIKE PARTICLE VACCINE
    Vang, Lo
    Guenther, Ben
    Uranga, Carla
    Mendy, Jason
    Betancourt, Elena
    Thompson, Danielle
    Aruri, Jayavani
    Smith, Jonathan
    Alexander, Jeffery
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 504 - 504
  • [38] Restriction of Zika Virus by Host Innate Immunity
    Xie, Xuping
    Shan, Chao
    Shi, Pei-Yong
    CELL HOST & MICROBE, 2016, 19 (05) : 566 - 567
  • [39] African Swine Fever Virus (ASFV): Immunity and Vaccine Development
    Chathuranga, Kiramage
    Lee, Jong-Soo
    VACCINES, 2023, 11 (02)
  • [40] Effects of dengue immunity on Zika virus infection
    Stephen S. Whitehead
    Theodore C. Pierson
    Nature, 2019, 567 (7749) : 467 - 468
12345